Cargando…
Projected 24-hour post-dose ocular itching scores post-treatment with olopatadine 0.7% versus 0.2%
Olopatadine is an antihistamine and mast cell stabilizer used for treating allergic conjunctivitis. Olopatadine 0.7% has been recently approved for daily dosing in the US, which supersedes the previously approved 0.2% strength. The objective of this analysis was to characterize patients who have bet...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061088/ https://www.ncbi.nlm.nih.gov/pubmed/29680872 http://dx.doi.org/10.1007/s10928-018-9588-7 |